Related Experiment Video
Updated: Feb 28, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Mechanisms of Tauroursodeoxycholate-Mediated Hepatoprotection
Dieter Häussinger1, Claus Kordes
1Clinic of Gastroenterology, Hepatology and Infectious Diseases, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Tauroursodeoxycholate (TUDC) promotes bile flow and protects liver cells by activating integrin signaling pathways. TUDC also stimulates stem cell differentiation, but this effect is not mediated by integrins.
Area of Science:
- Hepatology
- Cell Signaling
- Stem Cell Biology
Background:
- Tauroursodeoxycholate (TUDC) is known for its choleretic and hepatoprotective effects, used clinically for decades.
- The molecular mechanisms underlying TUDC's actions, particularly its signaling pathways, remain largely undefined.
- TUDC does not significantly activate classical bile acid receptors like FXR and TGR5.
Purpose of the Study:
- To elucidate the molecular mechanisms of TUDC's hepatoprotective and choleretic effects.
- To identify the receptors and signaling pathways involved in TUDC-mediated cellular responses.
- To investigate the role of integrins in TUDC signaling.
Main Methods:
- Investigated TUDC's interaction with cell surface receptors.
- Utilized cell signaling analysis to identify downstream effectors.
- Studied the impact of TUDC on mesenchymal stem cell differentiation.
Main Results:
- TUDC binds to α5β1-integrin, activating integrin signaling.
- Integrin activation leads to downstream signaling cascades (FAK, c-Src, EGFR, MAPK), promoting choleresis.
- TUDC-induced integrin activation triggers cAMP-dependent PKA, mediating anti-apoptotic effects.
- TUDC stimulates MSC differentiation independently of integrin signaling.
Conclusions:
- Integrins are key sensors for TUDC, mediating its choleretic and anti-apoptotic effects through specific signaling networks.
- TUDC's ability to promote hepatocyte-like cell differentiation from MSCs is a distinct pathway not involving integrins.
- Understanding TUDC's signaling network provides insights into novel therapeutic strategies for liver diseases.
Related Concept Videos
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Hepatic Drug Clearance: Role of Transporters
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Drug Metabolism: Phase II Reactions

